COVID-19 Vaccination and Serological Profile of a Brazilian University Population

Author:

Barreto Marina dos Santos1ORCID,Silva Beatriz Soares da1,Santos Ronaldy Santana1ORCID,Silva Deise Maria Rego Rodrigues1ORCID,Silva Eloia Emanuelly Dias1ORCID,Moura Pedro Henrique Macedo1,Souza Jessiane Bispo de1,Santana Lucas Alves da Mota2,Fonseca Dennyson Leandro M.3,Filgueiras Igor Salerno4ORCID,Guimarães Adriana Gibara1,Cabral-Marques Otavio3456789ORCID,Schimke Lena F.45ORCID,Borges Lysandro Pinto1ORCID

Affiliation:

1. Department of Pharmacy, Federal University of Sergipe, São Cristóvão 49100-000, SE, Brazil

2. Graduate Program in Dentistry, Federal University of Sergipe, São Cristóvão 49100-000, SE, Brazil

3. Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of São Paulo (USP), São Paulo 05508-090, SP, Brazil

4. Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, SP, Brazil

5. Department of Medicine, Division of Molecular Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, SP, Brazil

6. Department of Pharmacy and Postgraduate Program of Health and Science, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil

7. Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, São Paulo 01246-903, SP, Brazil

8. Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, SP, Brazil

9. Network of Immunity in Infection, Malignancy, Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), São Paulo 05508-000, SP, Brazil

Abstract

Background: COVID-19 led to the suspension academic activities worldwide, affecting millions of students and staff. Methods: In this study, we evaluated the presence of IgM and IgG anti-SARS-CoV-2 antibodies in an academic population during the return to classes after a one-year suspension. The study took place over five months at a Brazilian university and included 942 participants. Results: We found that most participants had reactive IgG and non-reactive IgM. All received at least one dose, and 940 received two or more doses, of different COVID-19 vaccines. We obtained a higher average of memory antibodies (IgG) in participants who received the CoronaVac/ChAdOx1 combination. IgG was consistently distributed for each vaccine group, but individuals who completed the vaccination schedule had higher levels. There were no differences between antibodies and gender, presence of symptoms, and previous COVID-19 infection, but older participants (>53 years) and contacts of infected individuals had higher IgM levels. Conclusion: This study makes significant contributions to the assessment of antibodies in the academic environment, allowing us to infer that most participants had memory immunity and low indications of recent infection when returning to face-to-face classes, as well as demonstrating the need to monitor immunity and update vaccinations.

Publisher

MDPI AG

Subject

Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics

Reference57 articles.

1. World Health Organization (2022, December 08). Origin of SARS-CoV-2. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/origins-of-the-virus.

2. Khan, M., Adil, S.F., Alkhathlan, H.Z., Tahir, M.N., Saif, S., Khan, M., and Khan, S.T. (2020). COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules, 26.

3. World Health Organization (2023, February 05). Schooling during the COVID-19. Recommendations from the European Technical Advisory Group for Schooling during COVID-19. Available online: http://apps.who.int/bookorders.

4. Brasil (2023, April 12). Poder Judiciário. Portaria Diretoria-Geral Nº 63, de 17 de Março de 2020. Available online: https://www.cnj.jus.br/wp-content/uploads/2020/03/Portaria_DG_632020.pdf.

5. COVID-19 Transmission at Schools in Japan;Akaishi;Tohoku J. Exp. Med.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3